pteridines has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In most patients with chronic myeloid leukemia (CML), the disease can be kept under control using the BCR/ABL kinase inhibitor imatinib." | 1.36 | Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536. ( Cerny-Reiterer, S; Ferenc, V; Gleixner, KV; Gruze, A; Hadzijusufovic, E; Mayerhofer, M; Meyer, RA; Peter, B; Pickl, WF; Sillaber, C; Valent, P, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mancini, M | 1 |
| De Santis, S | 1 |
| Monaldi, C | 1 |
| Bavaro, L | 1 |
| Martelli, M | 1 |
| Castagnetti, F | 1 |
| Gugliotta, G | 1 |
| Rosti, G | 1 |
| Santucci, MA | 1 |
| Martinelli, G | 1 |
| Cavo, M | 1 |
| Soverini, S | 1 |
| Gleixner, KV | 1 |
| Ferenc, V | 1 |
| Peter, B | 1 |
| Gruze, A | 1 |
| Meyer, RA | 1 |
| Hadzijusufovic, E | 1 |
| Cerny-Reiterer, S | 1 |
| Mayerhofer, M | 1 |
| Pickl, WF | 1 |
| Sillaber, C | 1 |
| Valent, P | 1 |
2 other studies available for pteridines and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors.
Topics: Aurora Kinase A; Benzamides; Cell Cycle Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Forkh | 2019 |
Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Cycle Prot | 2010 |